Skip to main content
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1980;58(2):293–296.

Effect of storage temperature on the stability of Lassa virus complement fixing antigen*

O Tomori
PMCID: PMC2395784  PMID: 6772319

Abstract

Inactivated Lassa virus complement-fixing antigen is normally prepared as a wet frozen antigen, and shipped in dry ice from the Center for Disease Control, Atlanta, Georgia, USA, to other laboratories not equipped for handling live Lassa virus. However, with this antigen there is a considerable loss of potency during shipping. In the search for a more stable antigen, inactivated Lassa antigen was lyophilized and subjected to different storage temperatures. Lyophilization did not significantly affect the CF titre, and the lyophilized antigen remained stable for 15 and 28 days at 25°C and 4°C, respectively.

Full text

PDF
293

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Greiff D., Rightsel W. A. Stabilities of suspensions of viruses after freezing or drying by vacuum sublimation and storage. Cryobiology. 1967 May-Jun;3(6):432–444. doi: 10.1016/s0011-2240(67)80153-6. [DOI] [PubMed] [Google Scholar]
  2. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  3. Wulff H., Lange J. V. Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull World Health Organ. 1975;52(4-6):429–436. [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES